276 related articles for article (PubMed ID: 16251318)
1. Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains.
Juan C; Maciá MD; Gutiérrez O; Vidal C; Pérez JL; Oliver A
Antimicrob Agents Chemother; 2005 Nov; 49(11):4733-8. PubMed ID: 16251318
[TBL] [Abstract][Full Text] [Related]
2. Model system to evaluate the effect of ampD mutations on AmpC-mediated beta-lactam resistance.
Schmidtke AJ; Hanson ND
Antimicrob Agents Chemother; 2006 Jun; 50(6):2030-7. PubMed ID: 16723562
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of the ampD gene in Pseudomonas aeruginosa leads to moderate-basal-level and hyperinducible AmpC beta-lactamase expression.
Langaee TY; Gagnon L; Huletsky A
Antimicrob Agents Chemother; 2000 Mar; 44(3):583-9. PubMed ID: 10681322
[TBL] [Abstract][Full Text] [Related]
4. NagZ inactivation prevents and reverts beta-lactam resistance, driven by AmpD and PBP 4 mutations, in Pseudomonas aeruginosa.
Zamorano L; Reeve TM; Deng L; Juan C; Moyá B; Cabot G; Vocadlo DJ; Mark BL; Oliver A
Antimicrob Agents Chemother; 2010 Sep; 54(9):3557-63. PubMed ID: 20566764
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of ampC in Pseudomonas aeruginosa mutants selected with ciprofloxacin.
Wolter DJ; Schmidtke AJ; Hanson ND; Lister PD
Antimicrob Agents Chemother; 2007 Aug; 51(8):2997-3000. PubMed ID: 17517839
[TBL] [Abstract][Full Text] [Related]
6. Selection and molecular characterization of ceftazidime/avibactam-resistant mutants in Pseudomonas aeruginosa strains containing derepressed AmpC.
Lahiri SD; Walkup GK; Whiteaker JD; Palmer T; McCormack K; Tanudra MA; Nash TJ; Thresher J; Johnstone MR; Hajec L; Livchak S; McLaughlin RE; Alm RA
J Antimicrob Chemother; 2015; 70(6):1650-8. PubMed ID: 25645206
[TBL] [Abstract][Full Text] [Related]
7. Constitutive high expression of chromosomal beta-lactamase in Pseudomonas aeruginosa caused by a new insertion sequence (IS1669) located in ampD.
Bagge N; Ciofu O; Hentzer M; Campbell JI; Givskov M; Høiby N
Antimicrob Agents Chemother; 2002 Nov; 46(11):3406-11. PubMed ID: 12384343
[TBL] [Abstract][Full Text] [Related]
8. Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins.
Berrazeg M; Jeannot K; Ntsogo Enguéné VY; Broutin I; Loeffert S; Fournier D; Plésiat P
Antimicrob Agents Chemother; 2015 Oct; 59(10):6248-55. PubMed ID: 26248364
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of AmpC over-expression in bloodstream isolates of Pseudomonas aeruginosa.
Tam VH; Schilling AN; LaRocco MT; Gentry LO; Lolans K; Quinn JP; Garey KW
Clin Microbiol Infect; 2007 Apr; 13(4):413-8. PubMed ID: 17359326
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of the glycoside hydrolase NagZ attenuates antipseudomonal beta-lactam resistance in Pseudomonas aeruginosa.
Asgarali A; Stubbs KA; Oliver A; Vocadlo DJ; Mark BL
Antimicrob Agents Chemother; 2009 Jun; 53(6):2274-82. PubMed ID: 19273679
[TBL] [Abstract][Full Text] [Related]
11. Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring high-level beta-lactam resistance involves three AmpD homologues.
Juan C; Moyá B; Pérez JL; Oliver A
Antimicrob Agents Chemother; 2006 May; 50(5):1780-7. PubMed ID: 16641450
[TBL] [Abstract][Full Text] [Related]
12. Role of ampD homologs in overproduction of AmpC in clinical isolates of Pseudomonas aeruginosa.
Schmidtke AJ; Hanson ND
Antimicrob Agents Chemother; 2008 Nov; 52(11):3922-7. PubMed ID: 18779353
[TBL] [Abstract][Full Text] [Related]
13. Deciphering β-lactamase-independent β-lactam resistance evolution trajectories in Pseudomonas aeruginosa.
Cabot G; Florit-Mendoza L; Sánchez-Diener I; Zamorano L; Oliver A
J Antimicrob Chemother; 2018 Dec; 73(12):3322-3331. PubMed ID: 30189050
[TBL] [Abstract][Full Text] [Related]
14. Impact of AmpC Derepression on Fitness and Virulence: the Mechanism or the Pathway?
Pérez-Gallego M; Torrens G; Castillo-Vera J; Moya B; Zamorano L; Cabot G; Hultenby K; Albertí S; Mellroth P; Henriques-Normark B; Normark S; Oliver A; Juan C
mBio; 2016 Oct; 7(5):. PubMed ID: 27795406
[TBL] [Abstract][Full Text] [Related]
15. Signalling proteins in enterobacterial AmpC beta-lactamase regulation.
Lindquist S; Galleni M; Lindberg F; Normark S
Mol Microbiol; 1989 Aug; 3(8):1091-102. PubMed ID: 2691840
[TBL] [Abstract][Full Text] [Related]
16. Providing β-lactams a helping hand: targeting the AmpC β-lactamase induction pathway.
Mark BL; Vocadlo DJ; Oliver A
Future Microbiol; 2011 Dec; 6(12):1415-27. PubMed ID: 22122439
[TBL] [Abstract][Full Text] [Related]
17. Activity of a new cephalosporin, CXA-101 (FR264205), against beta-lactam-resistant Pseudomonas aeruginosa mutants selected in vitro and after antipseudomonal treatment of intensive care unit patients.
Moya B; Zamorano L; Juan C; Pérez JL; Ge Y; Oliver A
Antimicrob Agents Chemother; 2010 Mar; 54(3):1213-7. PubMed ID: 20086158
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.
Riera E; Cabot G; Mulet X; García-Castillo M; del Campo R; Juan C; Cantón R; Oliver A
J Antimicrob Chemother; 2011 Sep; 66(9):2022-7. PubMed ID: 21653605
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype.
Jørgensen RL; Nielsen JB; Friis-Møller A; Fjeldsøe-Nielsen H; Schønning K
J Antimicrob Chemother; 2010 Mar; 65(3):460-4. PubMed ID: 20097787
[TBL] [Abstract][Full Text] [Related]
20. DHA-1 plasmid-mediated AmpC β-lactamase expression and regulation of Klebsiella pnuemoniae isolates.
Luan Y; Li GL; Duo LB; Wang WP; Wang CY; Zhang HG; He F; He X; Chen SJ; Luo DT
Mol Med Rep; 2015 Apr; 11(4):3069-77. PubMed ID: 25483576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
